EDR Peptide: Possible Mechanism of Gene Expression and Protein Synthesis Regulation Involved in the Pathogenesis of Alzheimer's Disease

This comprehensive study investigated the molecular mechanisms by which the EDR peptide (Glu-Asp-Arg), known as pinealon, may prevent the development of Alzheimer's disease. Using molecular and cell biology approaches, the researchers analyzed the effects of the peptide on signaling pathways, gene expression, and protein synthesis in oxidative stress models relevant to Alzheimer's pathogenesis.

The results demonstrated that the EDR peptide exerts its neuroprotective effects primarily through the MAPK/ERK signaling pathway (mitogen-activated protein kinases / extracellular signal-regulated kinases). Activation of this pathway promotes:

• Antiapoptotic effects, protecting neurons from programmed cell death
• Regulation of the expression of genes involved in neurodegeneration
• Modulation of the synthesis of key proteins associated with Alzheimer's pathology

A particularly relevant finding was the ability of EDR to prevent pathological changes under conditions of oxidative stress, one of the main triggering factors of the neurodegenerative cascade in Alzheimer's. The peptide demonstrated the capacity to modulate the expression of genes associated with amyloid precursor protein (APP) processing and tau phosphorylation.

The authors propose a model in which pinealon, being an extremely small peptide, can penetrate the cell nucleus and interact directly with specific DNA sequences, functioning as an endogenous epigenetic regulator. This mechanism is consistent with Khavinson's peptide bioregulation theory, which postulates that small peptides regulate gene expression in a tissue-specific manner. The findings suggest that pinealon may have potential as a preventive agent for Alzheimer's, especially in early stages of the disease.